Atlantic Union Bankshares’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8 Hold
5
﹤0.01% 1694
2026
Q1
$7 Hold
5
﹤0.01% 1742
2025
Q4
$9 Hold
5
﹤0.01% 1682
2025
Q3
$6 Sell
5
-385
-99% -$521 ﹤0.01% 1645
2025
Q2
$484 Buy
+390
New +$450 ﹤0.01% 1156

Other funds holding PACB

Atlantic Union Bankshares's PACB Position: Q2 2026 in Review

Atlantic Union Bankshares held its Pacific Biosciences (PACB) position steady in Q2 2026 at 5 shares worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #1694.

Atlantic Union Bankshares first reported a position in PACB in Q2 2025 and has held it in 5 quarters since. The position peaked at $484 in Q2 2025. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Atlantic Union Bankshares held 5 shares of Pacific Biosciences worth $8 as of Q2 2026.
  • Atlantic Union Bankshares left its Pacific Biosciences share count unchanged in Q2 2026.
  • Pacific Biosciences made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q2 2026, its #1694 holding.
  • Atlantic Union Bankshares first reported a position in Pacific Biosciences in Q2 2025 and has held it in 5 quarters since.
  • Atlantic Union Bankshares's Pacific Biosciences position peaked at $484 in Q2 2025.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.